IP Library Granted Patent US 9,745,556
Granted Patent B2
US 9,745,556 · App. 14/347,688 · Granted Aug 29, 2017

Variants of glycerol dehydrogenase having D-lactate dehydrogenase activity and uses thereof

Inventors: Qingzhao Wang (Scarsdale, NY); Keelnatham T. Shanmugam (Gainesville, FL); Lonnie O'Neal Ingram (Gainesville, FL)
Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
C12N9/0006C12P7/26C12P7/56C12P2203/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,745,556
App. No.
14/347,688
Granted
Aug 29, 2017
Kind
B2
Abstract

The present invention provides methods of designing and generating glycerol dehydrogenase (GlyDH) variants that have altered function as compared to a parent polypeptide. The present invention further provides nucleic acids encoding GlyDH polypeptide variants having altered function as compared to the parent polypeptide. Host cells comprising polynucleotides encoding GlyDH variants and methods of producing lactic acids are also provided in various aspects of the invention.

Claims (43)

1. An isolated polypeptide comprising the sequence of a glycerol dehydrogenase selected from SEQ ID NOs: 5-32 in which a phenylalanine has been substituted with an amino acid selected from serine, threonine, glycine or asparagine and, optionally, an aspartic acid has been substituted with an amino acid selected from glutamine or asparagine, wherein said phenylalanine corresponds to the phenylalanine at position 245 of SEQ ID NO: 5 and said aspartic acid corresponds to the aspartic acid at position 121 of SEQ ID NO: 5, and wherein the isolated polypeptide has D-lactate dehydrogenase activity.

2. The isolated polypeptide according to claim 1 , wherein said polypeptide comprises SEQ ID NO: 1.

3. The isolated polypeptide according to claim 1 , wherein said polypeptide comprises the sequence of a glycerol dehydrogenase selected from SEQ ID NOs: 5-32 in which a phenylalanine has been substituted with an amino acid selected from serine, threonine, glycine or asparagine and an aspartic acid has been substituted with an amino acid selected from glutamine or asparagine, wherein said phenylalanine corresponds to the phenylalanine at position 245 of SEQ ID NO: 5 and said aspartic acid corresponds to the aspartic acid at position 121 of SEQ ID NO: 5, and wherein the isolated polypeptide has D-lactate dehydrogenase activity.

4. The isolated polypeptide according to claim 1 , wherein only the phenylalanine that corresponds to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with an amino acid selected from serine, threonine, glycine or asparagine.

5. The isolated polypeptide according to claim 1 , wherein said polypeptide comprises amino acid substitutions selected from:

a) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with serine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

b) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with threonine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

c) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with threonine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with asparagine;

d) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with glycine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

e) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with glycine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with asparagine;

f) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with asparagine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

g) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with asparagine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with asparagine; and

h) only a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with an amino acid selected from serine, threonine, glycine or asparagine in said polypeptide.

6. The isolated polypeptide according to claim 1 , wherein said polypeptide consists of the sequence of the glycerol dehydrogenase with amino acid substitutions selected from:

a) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with serine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

b) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with threonine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

c) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with threonine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with asparagine;

d) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with glycine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

e) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with glycine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with asparagine;

f) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with asparagine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with glutamine;

g) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with asparagine and an aspartic acid corresponding to the aspartic acid at position 121 of SEQ ID NO: 5 has been substituted with asparagine; and

h) a phenylalanine corresponding to the phenylalanine at position 245 of SEQ ID NO: 5 has been substituted with an amino acid selected from serine, threonine, glycine or asparagine in said polypeptide.

7. A composition comprising a carrier and a polypeptide according to claim 1 .

8. The composition according to claim 7 , wherein said carrier comprises a hydrolysate derived from a biomass, a hemicellulosic biomass, a lignocellulosic biomass or a cellulosic biomass.

9. A composition comprising a diol and/or polyol and a polypeptide according to claim 1 .

10. The composition according to claim 9 , wherein the diol is 1,3-butanediol.

11. A method of producing 4-hydroxy-2-butanone comprising contacting 1,3-butanediol with a polypeptide according to claim 1 under conditions that result in the oxidation of 1,3-butanediol to 4-hydroxy-2-butanone.

12. An isolated nucleic acid comprising a polynucleotide encoding a polypeptide according to claim 1 .

13. A vector or genetic construct comprising a polynucleotide according to claim 12 .

14. An isolated microbial cell transformed with a nucleic acid according to claim 12 .

15. The isolated microbial cell according to claim 14 , wherein said microbial cell comprises a vector or genetic construct comprising said nucleic acid.

16. The isolated microbial cell according to claim 14 , wherein said microbial cell is a Gram-negative or a Gram-positive bacterial cell.

17. The isolated microbial cell according to claim 16 , wherein the Gram-negative bacterial cell is a bacterial cell selected from the genera of Escherichia, Zymomonas, Acinetobacter, Gluconobacter, Geobacter, Shewanella, Salmonella, Enterobacter or Klebsiella and the Gram-positive bacterial cell is a bacterial cell selected from the genera of Bacillus, Clostridium, Corynebacteria, Lactobacillus, Lactococcus, Oenococcus, Streptococcus and Eubacteria.

18. The isolated microbial cell according to claim 14 , wherein the microbial cell is Escherichia coli or Klebsiella oxytoca.

19. The isolated microbial cell according to claim 14 , wherein the microbial cell is selected from Thermoanaerobes, Bacillus spp., Paenibacillus spp. or Geobacillus spp.

20. The isolated microbial cell according to claim 14 , wherein the microbial cell is a yeast cell selected from a Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces , or Yarrowia cell.

21. The isolated microbial cell according to claim 20 , wherein the yeast cell is Kluyveromyces lactis, Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, Saccharomyces oviformis , or Yarrowia lipolytica.

22. The isolated microbial cell according to claim 14 , wherein said microbial cell is a fungal cell selected from an Acremonium, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Phlebia, Piromyces, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trametes , or Trichoderma cell.

23. The isolated microbial cell according to claim 22 , wherein said fungal cell is an Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Bjerkandera adusta, Ceriporiopsis aneirina, Ceriporiopsis caregiea, Ceriporiopsis gilvescens, Ceriporiopsis pannocinta, Ceriporiopsis rivulosa, Ceriporiopsis subrufa, Ceriporiopsis subvermispora, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium merdarium, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium tropicum, Chrysosporium zonatum, Coprinus cinereus, Coriolus hirsutus, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum, Humicola insolens, Humicola lanuginosa, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium purpurogenum, Phanerochaete chrysosporium, Phlebia radiata, Pleurotus eryngii, Thielavia terrestris, Trametes villosa, Trametes versicolor, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei , or Trichoderma viride cell.

24. A composition comprising culture medium and a transformed microbial cell according to claim 14 .

25. The composition according to claim 24 , wherein said culture medium comprises a hydrolysate derived from a biomass, a hemicellulosic biomass, a lignocellulosic biomass or a cellulosic biomass.

26. A method of making D-lactic acid comprising culturing a transformed microbial cell according to claim 14 in a culture medium under conditions that allow for the production of D-lactic acid.

27. The method according to claim 26 , wherein said culture medium comprises a hydrolysate derived from a biomass, a hemicellulosic biomass, a lignocellulosic biomass or a cellulosic biomass.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 3, 2014
From: UNIVERSITY OF FLORIDA
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 033114/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2014
From: WANG, QINGZHAO; SHANMUGAM, KEELNATHAM T.; INGRAM, LONNIE O.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 032540/0608 →
Continuity (2)
Provisional Application 61543003 · Oct 4, 2011
Related Publication 20140234924A1 · Aug 21, 2014